Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM: Effect of intensive insulin treatment

Diabetes Care

Volumn 21, Issue 6, 1998, Pages 1008-1013

  Albertini, Jean Paul ^a   Valensi, Paul ^b   Lormeau, Boris ^b   Aurousseau, Marie Hélène ^b   Ferrière, Francoise ^a   Attali, Jean Raymond ^b   Gattegno, Liliane ^b  

^a AVICENNE HOSPITAL   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; NEUTRAL INSULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FEMALE; HUMAN; INSULIN INFUSION; INSULIN TREATMENT; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

APOLIPOPROTEINS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; E-SELECTIN; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; REFERENCE VALUES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 3643137429     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.6.1008     Document Type: Article

References (25)

1. Koistinen MJ: Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301:92-95, 1990
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362: 801-809, 1993
3. Lorenzi M: Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev 8:85-103, 1992
4. Stauton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925-933, 1988
5. Diamond MS, Stauton DE, de Fougerolles AR: ICAM-1 (CD54) a counter-receptor for MAC-1 (CDllb/CD18). J Cell Biol 111: 3129-3139, 1990
6. Osbom L, Hession C, Tizard R, Vassalo C, Luhowsk JS, Chirosso G, Lobb R: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211, 1989
7. Carlos T, Kovach N, Schwanz B, Rosa M, Newman B, Waynes E, Benjamin C, Osborn L, Lobb R, HarlanJ: Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77:2266-2271, 1991
8. Pepinsky B, Hession C, Chen L-L, Moy P Burkly L, Jakubowsky A, Chow EP, Benjamin C, Chi-Rosso G, Luhoxskys S, Lobb R: Structure/function studies on vascular cell adhesion molecule-1. J Biol Chem 267:17820-17826, 1992
9. Stad RK, Buurman WA: Current views on structure and function of endothelial adhesion molecules. Cell Adhes Commun 2:261-268, 1994
10. Erbe DV, Barry A, Presta LG, Norton CR, Ramos RJ, Burns DK, Rumberge JM, Narasinga Rao BN, Foxall C, Brandley BK, Lasky LA: Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion. J Cell Biol 119:215-227, 1992
11. Luscinskas FW, Kansas GS, Ding H, Pizsueta P, Schleiffenbaum BE, Tedder TF, Gimbrone MA Jr: Monocyte rolling, arrest, and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, βl-integrins, and β2-integrins. J Cell Biol 125: 1417-1427, 1994
12. Richardson M, Hadcock SJ, Dereske M, Cybulsky MI: Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 14:760-769, 1994
13. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Jmmunol Today 14:506-512, 1993
14. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V: Elevated levels of soluble E-selectin, in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38:11221124, 1995
15. Fasching P, Waldhaüsl W, Wagner OF: Elevated circulating adhesiort molecules in NIDDM: potential mediator in diabetic macranigiopathy. Diabetologia 39:1242-1244, 1996
16. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD: Increased levels of soluble adhesion molecules in type 2 (noninsulin-dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984, 1994
17. Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorina AM, Lo Casio V: E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 40:584-589, 1997
18. Valensi P, Moura I, Le Magoarou M, Paries J, Perret G, Attali JR: Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in noninsulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabetes Metab 23:51-57, 1997
19. Benzie IF, Tomlinson B, Critchley JA: Captopril has no significant scavenging antioxidant activity in human plasma in vitro or in vivo. Br J Clin Pharmacol 44:209-210, 1997
20. Lormeau B, Aurousseau MH, Valensi P, Paries J, Attali JR: Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemie control with continuous insulin infusion in type II diabetic patients. Metabolism 46:1074-1079, 1997
21. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR: Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137:1798-1803, 1996
22. Muniyappa R, Walsh MF, Rangi JS, Zayas RM, Standley PR, Ram JL, Sowers JR: Insulin-like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci 61:925-931, 1997
23. Hackman A, Yasunori A, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr, Ballantyne CM: Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93:1334-1338, 1996
24. Cominacini L, Garbin U, Fratta Pasini A, Lo Cascio V: Increased levels of plasma ELAM1, ICAM-1, and VCAM-1 in NIDDM: possible role of oxidized LDL (Letter). Diabetologia 39:1244, 1996
25. Albertini J-P, Valensi P, Ferrière F, Lormeau B, Attali J-R, Gattegno L: Increase in serum levels of adhesion glycoproteins in NIDDM: effect of intensive insulin treatment (Abstract). Diabelologia 39 (Suppl. 1):A240, 1996